0001562180-21-007134.txt : 20211117
0001562180-21-007134.hdr.sgml : 20211117
20211117180519
ACCESSION NUMBER: 0001562180-21-007134
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211115
FILED AS OF DATE: 20211117
DATE AS OF CHANGE: 20211117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Russell Alan J
CENTRAL INDEX KEY: 0001853529
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40236
FILM NUMBER: 211421823
MAIL ADDRESS:
STREET 1: 3415 COLORADO AVE
CITY: BOULDER
STATE: CO
ZIP: 80303
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Edgewise Therapeutics, Inc.
CENTRAL INDEX KEY: 0001710072
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 821725586
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3415 COLORADO AVE.
CITY: BOULDER
STATE: CO
ZIP: 80303
BUSINESS PHONE: 303-735-8373
MAIL ADDRESS:
STREET 1: 3415 COLORADO AVE.
CITY: BOULDER
STATE: CO
ZIP: 80303
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2021-11-15
false
0001710072
Edgewise Therapeutics, Inc.
EWTX
0001853529
Russell Alan J
C/O EDGEWISE THERAPEUTICS, INC.
3145 COLORADO AVE.
BOULDER
CO
80303
true
true
false
false
Chief Scientific Officer
Common Stock
2021-11-15
4
S
false
441.00
19.0708
D
38.00
D
Common Stock
2021-11-15
4
S
false
38.00
19.61
D
0.00
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on June 17, 2021.
The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $18.56 to $19.52, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ John R. Moore, Attorney-in-Fact for Russell Alan J
2021-11-17